FDA approves a noninvasive way to get rid of double chins
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
On Wednesday, the Food and Drug Administration approved a new injectable drug that gets rid of double chins in a noninvasive way, eliminating the need to go under the knife.
Kybella is a version of deoxycholic acid that dissolves fat underneath the chin. Dr. Derek Jones told ABC News that the drug destroys a fat cell's membrane, causing it to burst. "When it disappears, it disappears permanently," he said. The entire process should take about five minutes, with doctors marking areas of the chin with small dots and then injecting tiny amounts of the substance into the dots. Patients will heal over the course of three days, and won't even need any bandages. The drug's manufacturer, Kythera Biopharmaceuticals, believes Kybella will be commercially available starting in June.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
